AC Immune ACIU
NASDAQ ACIU
$2.86 -0.07 (-2.39%)
At close: Sep 4, 2026 · 4:00 PM EDT

AC Immune (ACIU) Long-Term Debt Issuances (2017 - 2019)

AC Immune (ACIU) posted quarterly Long-Term Debt Issuances of -$50.6 million for Q4 2019, down 100811.09% year-over-year from N/an in Q4 2018, and down 200.23% quarter-over-quarter from $50.5 million in Q1 2019.

Analysis

AC Immune (ACIU) Long-Term Debt Issuances (2017 - 2019) Analysis & Trends

AC Immune (ACIU) has reported Long-Term Debt Issuances for 3 consecutive years, with -$50.6 million the latest figure, recorded in Q4 2019.

  • In Q4 2019, Long-Term Debt Issuances fell 100811.09% year-over-year to -$50.6 million; the TTM figure through Dec 2019 stood at -$116746.2 (down 104.21% YoY), while the FY2021 annual figure was $25.7 million, changed N/A from the prior year.
  • Long-Term Debt Issuances retreated to -$50.6 million in Q4 2019 per ACIU's latest filing, from $50.5 million in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $103.9 million in Q3 2017 and bottomed at -$101.2 million in Q4 2017.
  • Historically, Long-Term Debt Issuances has averaged $531074.0 across 3 years, with a median of $50241.7 in 2018.
  • Annual changes were most pronounced in 2018 — Long-Term Debt Issuances jumped 100.05% — and 2019, when it sank 100811.09%.
  • AC Immune's Long-Term Debt Issuances stood at -$101.2 million in 2017, then surged by 100.05% to $50241.7 in 2018, then tumbled by 100811.09% to -$50.6 million in 2019.
  • Business Quant data shows ACIU's Long-Term Debt Issuances at -$50.6 million in Q4 2019, $50.5 million in Q1 2019, and $50241.7 in Q4 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Issuances (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 AC Immune 285.13 Mn 285.13 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2019 50.48 Mn
Dec 31, 2018 -148,715.55
Dec 31, 2017 -101,357.93
Sep 30, 2017 50,925.74